InsidersTradesSigma
Follow the CYTORI THERAPEUTICS, INC. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 5 February 2016 (Attribution). Among the most active insiders: Girao Tiago. Every trade is openly available.
Analysts rate CYTORI THERAPEUTICS, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
CYTORI THERAPEUTICS, INC. is a company focused on developing therapies based on stem cells and biomaterials. It concentrates on treatments for medical conditions such as heart disease and tissue injuries.